Additivity of protein and nonprotein inhibitors of lung surfactant activity.
about
Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumoniaSurfactant therapy for bronchiolitis in critically ill infantsSurfactant therapy for bronchiolitis in critically ill infantsLung surfactant in subacute pulmonary disease.Altered Lipid Composition of Surfactant and Lung Tissue in Murine Experimental Malaria-Associated Acute Respiratory Distress SyndromeSurfactant for pediatric acute lung injurySurfactant therapy for acute lung injury and acute respiratory distress syndrome.Dynamic surface activity of a fully synthetic phospholipase-resistant lipid/peptide lung surfactant.A non-BRICHOS surfactant protein c mutation disrupts epithelial cell function and intercellular signalingPulmonary inflammation disrupts surfactant function during Pneumocystis carinii pneumonia.The surfactant protein C mutation A116D alters cellular processing, stress tolerance, surfactant lipid composition, and immune cell activation.Exogenous surfactant therapy in 2013: what is next? Who, when and how should we treat newborn infants in the future?Increased phospholipase A2 and lyso-phosphatidylcholine levels are associated with surfactant dysfunction in lung contusion injury in miceSurfactant dysfunction in lung contusion with and without superimposed gastric aspiration in a rat modelToxic effects of different meconium fractions on lung function: new therapeutic strategies for meconium aspiration syndrome?Overcoming inactivation of the lung surfactant by serum proteins: a potential role for fluorocarbons?Synthetic lung surfactants containing SP-B and SP-C peptides plus novel phospholipase-resistant lipids or glycerophospholipids.Activity and biophysical inhibition resistance of a novel synthetic lung surfactant containing Super-Mini-B DATK peptide.Nonionic polymers reverse inactivation of surfactant by meconium and other substances.Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs.Alveolar sphingolipids generated in response to TNF-alpha modifies surfactant biophysical activity.Surface activity of a synthetic lung surfactant containing a phospholipase-resistant phosphonolipid analog of dipalmitoyl phosphatidylcholine.Role of vagal innervation on pulmonary surfactant system during fetal development.Albumin mixed with meconium attenuates pulmonary dysfunction in a newborn piglet model with meconium aspiration.Meconium induced IL-8 production and intratracheal albumin alleviated lung injury in newborn pigs.Inhibition of surfactant activity by Pneumocystis carinii organisms and components in vitro.Total extracellular surfactant is increased but abnormal in a rat model of gram-negative bacterial pneumonia.
P2860
Q23918727-DDA8BF7D-E48D-443D-A32F-BB15BFE2EBE1Q24241134-4260998D-517F-4026-B927-D8B5F4F41ADFQ24245016-EAAF0E14-E180-4AFF-9F45-E9FD078C1598Q24807188-B807F17D-0961-454D-93B8-161F8AA3BADCQ28551232-A01D0E70-CBE4-4BB7-9140-132B496E0E51Q30409008-D59628F5-F77B-461B-9B15-7393C4CD4407Q30426177-DCE3EEB4-0F9D-42DD-A0B9-BD9386F77274Q33302898-21D262B2-E46D-4C21-8C09-8F2708E73FB2Q33751895-0F017445-BDE1-490E-BA07-7E97E154E0F4Q34005891-277D417F-2B9C-4964-857C-51594FB005DBQ34212504-71B6A874-2E9A-4BE2-A2B0-1CC6C6F47BADQ35013615-1983B2E5-C363-4A06-90F9-155C6D43F692Q36431321-7EC0452A-29EB-4E8B-A9F2-11154C4F0FB7Q37216217-DD86452D-683E-48AC-A776-9D8163FAE35EQ37341639-7EC6AF03-149C-42AF-995E-F43AD92CFEDEQ38537738-A6456E32-6F9B-4CE1-994D-36F0EAA91E99Q38798721-B3A631B7-0055-47A8-95AC-C5DB4A868783Q38917971-5450D029-2EC9-4C38-BD53-A8B9462A16A4Q41649821-BE4E1DB7-AF46-42CE-9729-CC3ACECBE649Q42153453-E1BFB4D9-38C7-4EF3-9A41-DC7CEF44FD92Q44187580-62A5850E-9E63-4BE9-A285-CCE7C37B14ADQ44539291-6099C7EE-D6D5-4DB9-AB43-DAE419E16FF8Q46082095-089E89BA-004C-45DB-9BB5-F71FEF129729Q51702301-70C6E9DB-CCD9-465F-B1BE-CA21343567C9Q51980865-8065A0B8-0638-4129-B4A6-A3FA8B98D67FQ52564201-C3B6AD8A-EC09-41E5-8F7C-6EC6331FD4CAQ54540320-CA9151FE-9FC5-4036-B19C-B6A684A75BEC
P2860
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh-hant
name
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@en
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@nl
type
label
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@en
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@nl
prefLabel
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@en
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@nl
P2860
P1476
Additivity of protein and nonprotein inhibitors of lung surfactant activity.
@en
P2093
P2860
P356
10.1164/AJRCCM.158.1.9709041
P407
P577
1998-07-01T00:00:00Z